Your session is about to expire
← Back to Search
Imaging Device
Ultrasound vs Veinviewer for Difficult IV Access
N/A
Waitlist Available
Led By Quincy Tran, MD, PhD
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who request Ultrasound guided peripheral IV (USGPIV)
Patients who are oriented to self (correct last name, first name), place (correct name of hospital), time (correct day of week or month of year) and person (correct name of current president)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 40 minutes
Awards & highlights
Study Summary
This trial will compare the ultrasound machine and the Vein Viewer, a near-infrared device, to see which is more efficient in helping patients with difficult intravenous access in emergency departments.
Who is the study for?
This trial is for patients who have trouble getting IVs placed because their veins are hard to see or feel. They must be able to identify themselves, the hospital, the date, and the current president. Only English speakers who can consent and aren't intoxicated or confused can join.Check my eligibility
What is being tested?
The study compares two devices used to help insert IVs in difficult cases: an ultrasound machine (Zonare) and a near-infrared device called Veinviewer. It aims to find out which one is more efficient in an emergency department setting.See study design
What are the potential side effects?
There may not be direct side effects from using Zonare or Veinviewer as they are non-invasive imaging technologies; however, discomfort or complications related to multiple attempts at IV insertion might occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am asking for an ultrasound-guided IV.
Select...
I know my name, where I am, the date, and the current president.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 40 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~40 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Operator's time
Secondary outcome measures
Cannulation time
ED length of stay
IV size
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: ZonareExperimental Treatment1 Intervention
108 patients are randomized to receive the intervention of using ultrasound machine (Zonare ZS3 machine) for IV cannulation. These patients will first undergo IV cannulation with assistance of the ultrasound machine.
Group II: VeinviewerExperimental Treatment1 Intervention
108 Patients are randomized to receive the Intervention of using the Veinviewer Flex machine for IV cannulation. These patients will first undergo IV cannulation with assistance of the Veinviewer Flex machine.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Veinviewer
2010
Completed Phase 4
~400
Find a Location
Who is running the clinical trial?
University of Maryland, BaltimoreLead Sponsor
691 Previous Clinical Trials
376,510 Total Patients Enrolled
Quincy Tran, MD, PhDPrincipal Investigator - University of Maryland
University of Maryland, College Park
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need immediate medical intervention due to unstable blood pressure or heart rate.I am under 18 years old.I am able to understand and consent to my treatment.I am asking for an ultrasound-guided IV.I know my name, where I am, the date, and the current president.
Research Study Groups:
This trial has the following groups:- Group 1: Veinviewer
- Group 2: Zonare
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities for individuals to join this clinical trial?
"Clinicaltrials.gov indicates that this particular study, which was first posted on the 1st of August 2016 and most recently edited on January 26th 2022, is not currently recruiting patients. Nonetheless, there are 11 other trials actively searching for candidates right now."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger